Topic Name

Message

If ARUP Consult does not answer your test selection and interpretation questions, or if you would like to suggest ways to improve content or usability, please send a message to the Consult editorial staff.

Please do not include any patient-specific or personal health information (PHI) in your message.

Email Address

An email address is not required, but providing one allows the ARUP Consult editorial staff to respond directly. ARUP will only use your email address to respond to your feedback. See the ARUP privacy policy for more information regarding email use.

CAPTCHA

What code is in the image?

Enter the characters shown in the image.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

NHF - MASAC Statement Regarding Use of Various Clotting Factor Assays to Monitor Factor Replacement Therapy

MASAC statement regarding use of various clotting factor assays to monitor factor replacement therapy. National Hemophilia Foundation. Issued Jun 2014; accessed Feb 2020.

Feedback

NHF - MASAC Statement Regarding Use of Various Clotting Factor Assays to Monitor Factor Replacement Therapy

What links here